NewsRoom Articles - Page 1279 of 1450

ThursdayJun 15, 2017 4:00 pm

PwrCor, Inc. (PWCO) Starts Presentation at the 2017 Marcum Microcap Conference

PwrCor (OTC: PWCO) is a clean energy technology company launching advanced solutions for the waste heat to energy, geothermal, and solar thermal markets. PwrCorTM engines use proprietary technology that can cost effectively convert ultra-low-grade heat to usable mechanical or electrical energy. PwrCorTM uses no fossil fuels, does not operate via combustion, has no emissions, and does not process any working fluids that are flammable, harmful to the environment, or costly to replace. PwrCorTM is scalable, modular, and runs relatively silently, all within a small footprint. For more information, visit the company's website at www.pwrcor.com About NetworkNewsWire NetworkNewsWire (NNW) is an…

ThursdayJun 15, 2017 4:00 pm

Nephros, Inc. (NEPH) Starts Presentation at the 2017 Marcum Microcap Conference

Nephros (OTC: NEPH) is a commercial-stage medical device company that develops and sells high performance liquid purification filters, as well as a hemodiafiltration system for the treatment of patients with End Stage Renal Disease. Nephros ultrafilters are used by dialysis centers for the removal of biological contaminants from the water and bicarbonate concentrate feeding hemodialysis devices. Nephros ultrafilters are used in hospitals and medical clinics as an aid in infection control by retaining bacteria, virus and endotoxin from water used by patients. For more information, visit the company's website at www.nephros.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

ThursdayJun 15, 2017 4:00 pm

Rxi Pharmaceuticals Corp. (NASDAQ: RXII) Starts Presentation at the 2017 Marcum Microcap Conference

Rxi Pharmaceuticals (NASDAQ: RXII) is a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs. RXi scientists have harnessed the naturally occurring RNAi process which has the ability to "silence" or down-regulate the expression of a specific gene that may be overexpressed in a disease condition. RXi's extensive patent portfolio provides for multiple product and business development opportunities across a broad spectrum of therapeutic areas and it actively pursues research collaborations, partnering and out-licensing opportunities with academia and pharmaceutical companies. For more information, visit the company's website at www.rxipharma.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

ThursdayJun 15, 2017 3:35 pm

PV Nano Cell (PVNNF) Increases IP War Chest as Japanese Patent Office Grants Silver Nano Particles Patent for 3D Printing

A recent Forbes (http://nnw.fm/4dz6G) article shows just how far Additive Manufacturing (AM), a.k.a. 3D Printing, has come, reporting that the government of Dubai, United Arab Emirates, ‘has set a target for 25 percent of buildings to be 3D-printed by 2030.’ Apparently, the AM industry now believes it has the technology to “print” houses. That technological prowess also appears to extend to smaller objects, much smaller, where the challenges are different but just as formidable. An Economist feature (http://nnw.fm/0D9oB) tells how a Chinese contract manufacturer is using 3D printers ‘to print electronic circuits, such as antennae and sensors, directly into products…

ThursdayJun 15, 2017 3:30 pm

Neurotrope, Inc. (NASDAQ: NTRP) Starts Presentation at the 2017 Marcum Microcap Conference

Neurotrope (NASDAQ: NTRP) is developing a novel therapy to treat and potentially reverse moderate to severe Alzheimer's dementia and other neurodegenerative diseases. The scientific basis of the treatment is activation of Protein Kinase C isozymes ε and α by Bryostatin-1, a natural product, which in mouse Alzheimer's disease models was demonstrated to result in repair of damaged synapses as well as synaptogenesis, the induction of new neuronal networks, reduction of toxic beta-amyloid generation, prevention of neuronal death, and enhancement of memory and learning, thus having the potential to improve cognition and behavior in Alzheimer's dementia. For more information, visit the…

ThursdayJun 15, 2017 3:30 pm

Jaguar Animal Health, Inc. (NASDAQ: JAGX) Starts Presentation at the 2017 Marcum Microcap Conference

Jaguar Animal Health (NASDAQ: JAGX) is an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses. Canalevia™ is Jaguar’s lead prescription drug product candidate, intended for the treatment of various forms of diarrhea in dogs. Equilevia™ is Jaguar’s prescription drug product candidate for the treatment of gastrointestinal ulcers in horses. Jaguar has nine active investigational new animal drug applications, or INADs, filed with the FDA. For more information, visit the company's website at jaguaranimalhealth.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access…

ThursdayJun 15, 2017 3:30 pm

Kush Bottles, Inc. (KSHB) Starts Presentation at the 2017 Marcum Microcap Conference

Kush Bottles (OTC: KSHB) is a dynamic sales platform that provides unique products and services for both businesses and consumers in the cannabis industry. Founded in 2010 as a packaging and supplies company for dispensaries and growers, Kush Bottles has sold more than 100 million units and now regularly services more than 4,000 legally operated medical and adult-use dispensaries, growers, and producers across North America, South America, and Europe. The company has facilities in the three largest U.S. cannabis markets and a local sales presence in every major U.S. cannabis market. For more information, visit the company's website at www.kushbottles.com…

ThursdayJun 15, 2017 3:30 pm

BioCorRx, Inc. (BICX) Starts Presentation at the 2017 Marcum Microcap Conference

BioCorRx (OTC: BICX) is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment program, consists of two main components. First is an outpatient implant procedure that delivers naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second is a proprietary counseling program tailored for treatment of alcoholism and substance abuse addictions and long-term naltrexone treatment. The company also has an R&D subsidiary, BioCorRx Pharmaceuticals, which is developing a new injectable naltrexone technology. For more information, visit the company’s website at…

ThursdayJun 15, 2017 3:30 pm

Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Starts Presentation at the 2017 Marcum Microcap Conference

Interpace Diagnostics Group (NASDAQ: IDXG) is focused on developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for better patient diagnosis and management. The company currently has three commercialized molecular tests; PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts; ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay and ThyraMIR, for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay. For more information, visit the company's website at www.interpacediagnostics.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to…

ThursdayJun 15, 2017 3:30 pm

Takung Art Co. Ltd. (NYSE: TKAT) Starts Presentation at the 2017 Marcum Microcap Conference

Takung Art (NYSE: TKAT) is an online trading platform for acquiring shared ownership in Asian and other fine art, jewelry and precious gems. This proprietary platform allows collectors and investors - including those with modest financial resources - to buy and sell units of these assets and participate in the booming Asian art market. The company's shared-ownership business model significantly expands the number of interactions between sellers and buyers of fine art far beyond those generated by art galleries and auction houses alone. For more information, visit the company's website at www.takungart.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

PwrCor, Inc. (PWCO) Starts Presentation at the 2017 Marcum Microcap Conference

Nephros, Inc. (NEPH) Starts Presentation at the 2017 Marcum Microcap Conference

Rxi Pharmaceuticals Corp. (NASDAQ: RXII) Starts Presentation at the 2017 Marcum Microcap Conference

PV Nano Cell (PVNNF) Increases IP War Chest as Japanese Patent Office Grants Silver Nano Particles Patent for 3D Printing

Neurotrope, Inc. (NASDAQ: NTRP) Starts Presentation at the 2017 Marcum Microcap Conference

Jaguar Animal Health, Inc. (NASDAQ: JAGX) Starts Presentation at the 2017 Marcum Microcap Conference

Kush Bottles, Inc. (KSHB) Starts Presentation at the 2017 Marcum Microcap Conference

BioCorRx, Inc. (BICX) Starts Presentation at the 2017 Marcum Microcap Conference

Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Starts Presentation at the 2017 Marcum Microcap Conference

Takung Art Co. Ltd. (NYSE: TKAT) Starts Presentation at the 2017 Marcum Microcap Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search